Over the weekend, several U.S. Food and Drug Administration employees, including those overseeing Elon Musk’s Neuralink brain implant trials, were dismissed as part of a wider federal workforce reduction, according to anonymous sources. The cuts affected about 20 personnel from the FDA’s neurological devices office.
About the Author
